State of New Jersey Common Pension Fund D’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-72,544
Closed -$2.85M 1690
2023
Q2
$2.85M Sell
72,544
-47,866
-40% -$1.69M 0.01% 977
2023
Q1
$2.93M Buy
120,410
+13,266
+12% +$290K 0.01% 884
2022
Q4
$2.29M Buy
+107,144
New +$2.29M 0.01% 1163
2017
Q1
Sell
-17,500
Closed -$85K 966
2016
Q4
$85K Hold
17,500
﹤0.01% 932
2016
Q3
$807K Hold
17,500
﹤0.01% 836
2016
Q2
$893K Hold
17,500
﹤0.01% 826
2016
Q1
$740K Hold
17,500
﹤0.01% 849
2015
Q4
$1.37M Hold
17,500
0.01% 793
2015
Q3
$709K Hold
17,500
﹤0.01% 872
2015
Q2
$911K Hold
17,500
﹤0.01% 853
2015
Q1
$814K Hold
17,500
﹤0.01% 866
2014
Q4
$785K Hold
17,500
﹤0.01% 894
2014
Q3
$681K Hold
17,500
﹤0.01% 872
2014
Q2
$740K Buy
+17,500
New +$642K ﹤0.01% 869

State of New Jersey Common Pension Fund D's ISEE Position: Q3 2023 in Review

State of New Jersey Common Pension Fund D sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 72,544 shares — an estimated $2.85M sold.

State of New Jersey Common Pension Fund D first reported a position in ISEE in Q2 2014 and held it in 14 quarters. The position peaked at $2.93M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • State of New Jersey Common Pension Fund D reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 72,544 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.85M.
  • State of New Jersey Common Pension Fund D first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 14 quarters.
  • State of New Jersey Common Pension Fund D's IVERIC bio, Inc. Common Stock position peaked at $2.93M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2023, filed 8 Nov 2023.